Click here to get full coverage on Merck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 Congress - simplywall.st

Merck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 Congress  simplywall.st

Merck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 Congress - simplywall.st

Click here to get full coverage on Merck (MRK): Valuation Update Following FDA Breakthrough in Oncology and New Approvals - Yahoo Finance

Merck (MRK): Valuation Update Following FDA Breakthrough in Oncology and New Approvals  Yahoo Finance

Merck (MRK): Valuation Update Following FDA Breakthrough in Oncology and New Approvals - Yahoo Finance

Click here to get full coverage on How Merck & Company Inc. (MRK) Affects Rotational Strategy Timing - news.stocktradersdaily.com

How Merck & Company Inc. (MRK) Affects Rotational Strategy Timing  news.stocktradersdaily.com

How Merck & Company Inc. (MRK) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Click here to get full coverage on 19M Global Deaths: Merck Tackles World's Leading Killer with Breakthrough Heart Disease Research at ESC - Stock Titan

19M Global Deaths: Merck Tackles World's Leading Killer with Breakthrough Heart Disease Research at ESC  Stock Titan

19M Global Deaths: Merck Tackles World's Leading Killer with Breakthrough Heart Disease Research at ESC - Stock Titan

Click here to get full coverage on Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now? - Zacks Investment Research

Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now?  Zacks Investment Research

Exelixis vs. Merck: Which Oncology Stock Is a Better Pick as of Now? - Zacks Investment Research

Click here to get full coverage on Merck shares snapped six-session winning streak (NYSE:MRK) - Seeking Alpha

Merck shares snapped six-session winning streak (NYSE:MRK)  Seeking Alpha

Merck shares snapped six-session winning streak (NYSE:MRK) - Seeking Alpha

Click here to get full coverage on Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness - Yahoo Finance

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness  Yahoo Finance

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness - Yahoo Finance

Click here to get full coverage on Merck (MRK) Valuation in Focus After FDA Breakthrough Therapy Designation for Lung Cancer Drug - simplywall.st

Merck (MRK) Valuation in Focus After FDA Breakthrough Therapy Designation for Lung Cancer Drug  simplywall.st

Merck (MRK) Valuation in Focus After FDA Breakthrough Therapy Designation for Lung Cancer Drug - simplywall.st

Click here to get full coverage on FDA Breakthrough for Lung Cancer Drug Might Change the Case For Investing In Merck (MRK) - Yahoo Finance

FDA Breakthrough for Lung Cancer Drug Might Change the Case For Investing In Merck (MRK)  Yahoo Finance

FDA Breakthrough for Lung Cancer Drug Might Change the Case For Investing In Merck (MRK) - Yahoo Finance

Click here to get full coverage on Shareholders Can Be Confident That Merck's (NYSE:MRK) Earnings Are High Quality - simplywall.st

Shareholders Can Be Confident That Merck's (NYSE:MRK) Earnings Are High Quality  simplywall.st

Shareholders Can Be Confident That Merck's (NYSE:MRK) Earnings Are High Quality - simplywall.st

Click here to get full coverage on Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRM - Yahoo Finance

Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRM  Yahoo Finance

Oppenheimer Considers Merck & Co. (MRK) Agreement as Strong Endorsement for Veeva’s Vault CRM - Yahoo Finance

Click here to get full coverage on Merck (MRK) Antibody Drug Ifinatamab Deruxtecan Gains Breakthrough Therapy Designation - Yahoo Finance

Merck (MRK) Antibody Drug Ifinatamab Deruxtecan Gains Breakthrough Therapy Designation  Yahoo Finance

Merck (MRK) Antibody Drug Ifinatamab Deruxtecan Gains Breakthrough Therapy Designation - Yahoo Finance

Click here to get full coverage on We Think Merck's (NYSE:MRK) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

We Think Merck's (NYSE:MRK) Profit Is Only A Baseline For What They Can Achieve  Yahoo Finance

We Think Merck's (NYSE:MRK) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance

Click here to get full coverage on Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It  Yahoo Finance

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Click here to get full coverage on Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline - Yahoo Finance

Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline  Yahoo Finance

Merck & Co. (MRK) Slid on Weaker Market Sentiment and Concerns About Drug Pipeline - Yahoo Finance

Click here to get full coverage on Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial - Yahoo Finance

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial  Yahoo Finance

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial - Yahoo Finance

Click here to get full coverage on Why Merck (MRK) Shares Are Sliding Today - Yahoo Finance

Why Merck (MRK) Shares Are Sliding Today  Yahoo Finance

Why Merck (MRK) Shares Are Sliding Today - Yahoo Finance

Click here to get full coverage on MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer - Yahoo Finance

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer  Yahoo Finance

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer - Yahoo Finance

Click here to get full coverage on Merck & Co Inc (MRK) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Merck & Co Inc (MRK) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...  Yahoo Finance

Merck & Co Inc (MRK) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Click here to get full coverage on Why Merck (MRK) is a Top Value Stock for the Long-Term - Yahoo Finance

Why Merck (MRK) is a Top Value Stock for the Long-Term  Yahoo Finance

Why Merck (MRK) is a Top Value Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know  Yahoo Finance

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Click here to get full coverage on Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?  Yahoo Finance

Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Click here to get full coverage on Marex Group plc (MRK) to Acquire Winterflood Securities - Yahoo Finance

Marex Group plc (MRK) to Acquire Winterflood Securities  Yahoo Finance

Marex Group plc (MRK) to Acquire Winterflood Securities - Yahoo Finance

Click here to get full coverage on UBS Bullish on Merck (MRK) Following Verona Pharma Purchase - Yahoo Finance

UBS Bullish on Merck (MRK) Following Verona Pharma Purchase  Yahoo Finance

UBS Bullish on Merck (MRK) Following Verona Pharma Purchase - Yahoo Finance

Click here to get full coverage on Merck KGaA's (ETR:MRK) Earnings Seem To Be Promising - Yahoo Finance

Merck KGaA's (ETR:MRK) Earnings Seem To Be Promising  Yahoo Finance

Merck KGaA's (ETR:MRK) Earnings Seem To Be Promising - Yahoo Finance

Click here to get full coverage on Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations - Yahoo Finance

Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations  Yahoo Finance

Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations - Yahoo Finance

Click here to get full coverage on Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade  Yahoo Finance

Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance

Click here to get full coverage on What To Expect From Merck’s (MRK) Q2 Earnings - Yahoo Finance

What To Expect From Merck’s (MRK) Q2 Earnings  Yahoo Finance

What To Expect From Merck’s (MRK) Q2 Earnings - Yahoo Finance

Click here to get full coverage on Merck & Co., Inc. (MRK) Is Unlikely To Face Antitrust Action For Verona Deal, Says Jim Cramer - Yahoo Finance

Merck & Co., Inc. (MRK) Is Unlikely To Face Antitrust Action For Verona Deal, Says Jim Cramer  Yahoo Finance

Merck & Co., Inc. (MRK) Is Unlikely To Face Antitrust Action For Verona Deal, Says Jim Cramer - Yahoo Finance

Click here to get full coverage on Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating - Yahoo Finance

Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating  Yahoo Finance

Goldman Sachs Reduced the PT on Merck & Co., Inc. (MRK), Kept a Buy Rating - Yahoo Finance

Click here to get full coverage on Our Q2 2025 financial results - Merck.com

Our Q2 2025 financial results  Merck.com

Our Q2 2025 financial results - Merck.com

Click here to get full coverage on Merck’s (MRK) Dividend History: A Track Record of Consistency - Yahoo Finance

Merck’s (MRK) Dividend History: A Track Record of Consistency  Yahoo Finance

Merck’s (MRK) Dividend History: A Track Record of Consistency - Yahoo Finance

Click here to get full coverage on Why Merck (MRK) is a Top Value Stock for the Long-Term - Nasdaq

Why Merck (MRK) is a Top Value Stock for the Long-Term  Nasdaq

Why Merck (MRK) is a Top Value Stock for the Long-Term - Nasdaq

Click here to get full coverage on Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial - MSN

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial  MSN

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial - MSN

Click here to get full coverage on Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet - Yahoo Finance

Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet  Yahoo Finance

Brokers Suggest Investing in Merck (MRK): Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Is Wall Street Bullish or Bearish on Merck Stock? - Yahoo Finance

Is Wall Street Bullish or Bearish on Merck Stock?  Yahoo Finance

Is Wall Street Bullish or Bearish on Merck Stock? - Yahoo Finance

Click here to get full coverage on Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup - Yahoo Finance

Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup  Yahoo Finance

Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup - Yahoo Finance

Click here to get full coverage on Merck (MRK) Announces Positive Phase 3 Trial Results For KEYTRUDA In Bladder Cancer Treatment - Yahoo Finance

Merck (MRK) Announces Positive Phase 3 Trial Results For KEYTRUDA In Bladder Cancer Treatment  Yahoo Finance

Merck (MRK) Announces Positive Phase 3 Trial Results For KEYTRUDA In Bladder Cancer Treatment - Yahoo Finance

Click here to get full coverage on Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings? - Yahoo Finance

Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?  Yahoo Finance

Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings? - Yahoo Finance

Click here to get full coverage on Merck (MRK) Revises 2025 Sales Guidance and Reports Lower Q2 Earnings - Yahoo Finance

Merck (MRK) Revises 2025 Sales Guidance and Reports Lower Q2 Earnings  Yahoo Finance

Merck (MRK) Revises 2025 Sales Guidance and Reports Lower Q2 Earnings - Yahoo Finance

Click here to get full coverage on Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for  Yahoo Finance

Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Click here to get full coverage on Merck (MRK) Collaborates On Virtual Tumor Models To Advance Cancer Research - Yahoo Finance

Merck (MRK) Collaborates On Virtual Tumor Models To Advance Cancer Research  Yahoo Finance

Merck (MRK) Collaborates On Virtual Tumor Models To Advance Cancer Research - Yahoo Finance

Click here to get full coverage on Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It” - Yahoo Finance

Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It”  Yahoo Finance

Jim Cramer on Merck’s Latest Quarterly Report: “I Actually Liked It” - Yahoo Finance

Click here to get full coverage on Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer - Yahoo Finance

Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer  Yahoo Finance

Merck & Co., Inc. (MRK)’s CEO Thinks He’s Got $50 Billion Of New Drugs, Says Jim Cramer - Yahoo Finance

Click here to get full coverage on Merck Moves Past 50-Day Average: How to Play MRK Stock Now - Yahoo Finance

Merck Moves Past 50-Day Average: How to Play MRK Stock Now  Yahoo Finance

Merck Moves Past 50-Day Average: How to Play MRK Stock Now - Yahoo Finance

Click here to get full coverage on MRK Q2 Deep Dive: Pipeline Strength and New Product Launches Highlight Transition Period - Yahoo Finance

MRK Q2 Deep Dive: Pipeline Strength and New Product Launches Highlight Transition Period  Yahoo Finance

MRK Q2 Deep Dive: Pipeline Strength and New Product Launches Highlight Transition Period - Yahoo Finance

Click here to get full coverage on Merck (MRK) Declares Fourth Dividend US$0.81; Keytruda Gains Approval for Cervical Cancer - Yahoo Finance

Merck (MRK) Declares Fourth Dividend US$0.81; Keytruda Gains Approval for Cervical Cancer  Yahoo Finance

Merck (MRK) Declares Fourth Dividend US$0.81; Keytruda Gains Approval for Cervical Cancer - Yahoo Finance

Click here to get full coverage on Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know  Yahoo Finance

Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Click here to get full coverage on Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’ - Yahoo Finance

Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’  Yahoo Finance

Analyst Says Merck (MRK) is ‘Really Cheap’ But Warns About Potential ‘Bad News’ - Yahoo Finance

Click here to get full coverage on MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE - Yahoo Finance

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE  Yahoo Finance

MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOE - Yahoo Finance

Click here to get full coverage on 3 Reasons Why Merck (MRK) Stock Remains a Top Investment Idea Right Now - TIKR.com

3 Reasons Why Merck (MRK) Stock Remains a Top Investment Idea Right Now  TIKR.com

3 Reasons Why Merck (MRK) Stock Remains a Top Investment Idea Right Now - TIKR.com

Click here to get full coverage on Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating - MSN

Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating  MSN

Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating - MSN

Click here to get full coverage on Should You Buy MRK Stock At $80? - Forbes

Should You Buy MRK Stock At $80?  Forbes

Should You Buy MRK Stock At $80? - Forbes

Click here to get full coverage on MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer - The Globe and Mail

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer  The Globe and Mail

MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer - The Globe and Mail

Click here to get full coverage on Will Merck Stock Rise On Its Upcoming Earnings? - Trefis

Will Merck Stock Rise On Its Upcoming Earnings?  Trefis

Will Merck Stock Rise On Its Upcoming Earnings? - Trefis

Click here to get full coverage on Merck & Co. (MRK) Divests Surface Solutions for €665 million - MSN

Merck & Co. (MRK) Divests Surface Solutions for €665 million  MSN

Merck & Co. (MRK) Divests Surface Solutions for €665 million - MSN

Click here to get full coverage on Merck & Co., Inc. (MRK) Breaks Ground on $1B Biologics Hub to Boost KEYTRUDA Production - Yahoo Finance

Merck & Co., Inc. (MRK) Breaks Ground on $1B Biologics Hub to Boost KEYTRUDA Production  Yahoo Finance

Merck & Co., Inc. (MRK) Breaks Ground on $1B Biologics Hub to Boost KEYTRUDA Production - Yahoo Finance

Click here to get full coverage on Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating - Yahoo Finance

Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating  Yahoo Finance

Jefferies Raises Merck (MRK) Price Target, Maintains Buy Rating - Yahoo Finance

Click here to get full coverage on The one-year underlying earnings growth at Merck (NYSE:MRK) is promising, but the shareholders are still in the red over that time - Yahoo Finance

The one-year underlying earnings growth at Merck (NYSE:MRK) is promising, but the shareholders are still in the red over that time  Yahoo Finance

The one-year underlying earnings growth at Merck (NYSE:MRK) is promising, but the shareholders are still in the red over that time - Yahoo Finance

Click here to get full coverage on Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now? - Yahoo Finance

Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?  Yahoo Finance

Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Is Merck & Co., Inc. (MRK) the Best Dow Stock? - Yahoo Finance

Is Merck & Co., Inc. (MRK) the Best Dow Stock?  Yahoo Finance

Is Merck & Co., Inc. (MRK) the Best Dow Stock? - Yahoo Finance

Click here to get full coverage on Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged - Yahoo Finance

Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged  Yahoo Finance

Jefferies Maintains a Buy Rating on Merck & Co. (MRK), Keeps the PT Unchanged - Yahoo Finance

Click here to get full coverage on MRK Holdings First Quarter 2026 Earnings: JP¥1.84 loss per share (vs JP¥2.63 loss in 1Q 2025) - simplywall.st

MRK Holdings First Quarter 2026 Earnings: JP¥1.84 loss per share (vs JP¥2.63 loss in 1Q 2025)  simplywall.st

MRK Holdings First Quarter 2026 Earnings: JP¥1.84 loss per share (vs JP¥2.63 loss in 1Q 2025) - simplywall.st

Click here to get full coverage on Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat? - Yahoo Finance

Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?  Yahoo Finance

Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat? - Yahoo Finance

Click here to get full coverage on Merck & Co (MRK) Announces the Approval of ENFLONSIA - Yahoo Finance

Merck & Co (MRK) Announces the Approval of ENFLONSIA  Yahoo Finance

Merck & Co (MRK) Announces the Approval of ENFLONSIA - Yahoo Finance

Click here to get full coverage on Texas declares an end to measles outbreak (MRK:NYSE) - Seeking Alpha

Texas declares an end to measles outbreak (MRK:NYSE)  Seeking Alpha

Texas declares an end to measles outbreak (MRK:NYSE) - Seeking Alpha

Click here to get full coverage on What’s Next For Merck After A Q1 Beat? - Trefis

What’s Next For Merck After A Q1 Beat?  Trefis

MRK

Price Chart

Key Statistics

Technicals

About MRK

Latest News

Merck (MRK) Unveils New Cardiovascular Research Data at ESC 2025 Congress - simplywall.st

Merck (MRK): Valuation Update Following FDA Breakthrough in Oncology and New Approvals - Yahoo Finance

How Merck & Company Inc. (MRK) Affects Rotational Strategy Timing - news.stocktradersdaily.com

Advanced Charts

Top Gainers

Top Losers